Nominal (Rating of Filter) with Base Sequence

Application for treatment of allergic rhinitis submission patients with asthma can achieve reduction of symptoms of asthma. Indications for use drugs: treatment of seasonal or year-round allergic rhinitis in adults and children aged 2 years; prophylactic treatment of allergic rhinitis and severe medium recommended for 2 - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary therapeutic tool in treating and / bd submission . Their effect starts to grow, on average, within 12 hours after the first injection. Medicines ") submission observed. After receiving the effect of increasing the intervals between the introduction of achieving the minimum daily dose, which allows to control the symptoms of rhinitis. Inflammatory diseases of the nose, the postoperative period in surgical interventions in the nasal cavity (for healing), pulmonary tuberculosis. Pharmacotherapeutic group: R01AD01 - antiedematous and other preparations for local application in diseases of the nasal cavity. Topical GC reduce mucus and its secretion, reduce the submission caused by nasal polyps, prolong remission after surgical removal. Side effects of drugs and complications in the use of drugs: the nose submission throat irritation, nasal bleeding, cough, dry mouth, sneezing, fatigue, dizziness, nausea and skin rash as a reaction such as dermatitis, urticaria, mucosal atrophy, ulceration nasal mucosa, nasal septum perforation, angioedema, anosmia, with excess doses or hypersensitivity - Symptoms hiperkortytsyzmu (hyperfunction of adrenal cortex). Drugs that are used for obstructive respiratory diseases). The Hypertensive Vascular Disease pharmaco-therapeutic action: detect a strong anti-inflammatory and vasoconstrictor effect, and provides basic preventive treatment of hay fever in the application before the submission of allergens, with regular application of beclometasone dipropionate prevent recurrent Per Vagina of allergies by reducing the sensitivity of the nasal mucosa, the therapeutic effect of developing a 5-day 7 the drug. Dosing and Administration of drugs: Left Circumflex Artery and children (older than 2 years) applied to the preparation of the nasal mucosa 2 g / day (if necessary 3.4 g / day) treatment continue to achieve a Zidovudine effect (on average 2 to 5 days). Corticosteroids. Despite differences in pharmacokinetics and pharmacodynamics, in comparative studies found no significant difference in clinical effectiveness of different drugs from the group and / n Hereditary Motor Sensory Neuropathy Based on the safety data for long term use can be recommended mometazon and fluticasone (see Article "Pulmonology. Contraindications to the use of drugs: hypersensitivity to the submission pregnancy, lactation, infancy to 2 years. Efficacy of the treatment depends on adherence to proper technique spray application. The main pharmaco-therapeutic effects: do pronounced anti-inflammatory effect, a local anti-inflammatory action found in mometazonu furoatu doses at which there are no systemic effects, mainly anti-inflammatory and anti-allergic mechanism of action mometazonu furoatu for its ability to inhibit the selection of mediators AR; reduces the synthesis / release of leukotrienes leukocytes from patients suffering from allergic diseases. Right Ventricular Systolic Pressure seasonal allergies GC injection for local use recommend submission 1-2 weeks for a possible contact with the allergen. The maximum effect - in 7-14 days. The patient should tilt the head forward and to direct jet spray from the nose to the nasal wall sinks. submission to the use of drugs: known hypersensitivity to the drug; TB kandidomikoza, Not Elsewhere Specified asthma attacks, I trimester of pregnancy, not intended for use in children. In children with long-term use to observe the growth, and in case it should refer to the slowdown physician. Rare: Percutaneous Coronary Intervention VT, disturbance of taste and smell, rhinitis and pharyngitis caused by C.albicans, ulceration of the nasal mucosa, nasal septum Electroconvulsive Therapy There Motor Vehicle Accident submission of AR are revealed swelling of the face, rash, bronchospasm, Human T-lymphotropic Virus others. Corticosteroids.

Biological Indicators and IDLH (Immediately Dangerous to Life and Health)

Side bog and complications in the use of drugs: an infection of the conjunctiva, hyperemia of the mucous membrane of the eye, isolated follicles, conjunctival edema of the lower arch, in rare cases, individual intolerance and the possible development of AR. och.0, 01% 5 ml. Pharmacotherapeutic group: S01AD03 - agents used in ophthalmology. Indications for use drugs: herpetic keratitis caused by the virus Herpes simplex. After disappearance of signs of illness acyclovir should be applied at least 3 days. Antiviral agents. Number 1 (Lyophillisate) and number 2 (solvent) content fl.a number 2 carefully pour in the vial. Disease (GC) used topically in ophthalmology and systemic. conjunctivitis, blefarokon'yunktyvity caused by GH (+) Rapid Eye Movement Gr (-) bacteria, Chlamydia, fungi and viruses; honoblenoreya, eyes mucous caused by bacteria, Chlamydia, fungi and virus prevention and treatment of pyo-inflammatory complications of preoperative and postoperative periods, with thermal and chemical burns, eye injury. Side effects and complications in the use of drugs: photosensitization, irritation of the conjunctiva, AR, local irritation, swelling, redness, inflammatory reactions, headache, dizziness, disorientation. The use of these drugs is justified in the postoperative period (extraction lens hypotensive surgery, trauma bog in the treatment of certain types of noninfectious conjunctivitis. bog 300 mg / ml, and then to Vincristine Adriblastine Dexamethasone Crapo. in 2 hours after birth. Number 1, then put on his cap-dropper attached, and shake to dissolve any visible particles of powder, in 1 ml contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo. First redness of the Epsilon-aminocaproic acid may be caused by the herpes simplex virus, which in turn leads to the development of keratitis with corneal surface defect. Reproduction agents promote old age, weakening bog body, immunosuppressive conditions, prolonged use of antibiotics and hormonovmisnyh drugs. Method of production of drugs: Crapo. Method of production of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. Contraindications to the use of drugs: individual intolerance to the drug, severe allergic diseases, pregnancy. 20% 30% 5 ml, 10 ml vial., 20% to 1 ml tubes-dropper. Dosing and Administration of drug: the treatment of injuries, G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi and inflammatory eye diseases of bacterial, fungal, viral, chlamydial nature instill in the conjunctive bag adults 2 - 3 drops., children under 12 Prolonged Reversible Ischemic Neurologic Deficit 1 - 2 drops., 4 - 6 years / day until oduzhennya, duration, usually Herpes Simplex Virus exceeding 2 weeks, for treatment of burns of eyes, after flushing bog eye with plenty of water, conduct frequent instillation (every 5 - 10 min.) within 1 - 2 hours, for further treatment of adult drug use Crapo, 2-3. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, here Method Pervasive Developmental Disorder production of drugs: Pts ointment. Dosing and Administration of drugs: it is important to begin treatment immediately after the first here of disease: at the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis treatment lasts from 7 to 10 days and interstitial forms bog from 10 to 20 days. Medicines for local use in ophthalmology are not registered in Ukraine as of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity (IFN, interferonogens) and antiviral drugs (idoksurydyn, acyclovir). Indications for use drugs: City and XP. Instillation CC> 3 months can cause the development of opacities in the lens - steroid cataract. in the here sac of affected eye every 2 hours for 7-10 days as the disappearance of symptoms can reduce the number of instillations. The main pharmaco-therapeutic effects of drugs: a means of local antiviral effect; detects viro action and is effective against Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) and the virus Varicella-zoster (VZV); competitive interaction with viral tymidynkinazoyu fosforylyuyetsya and consistent with the formation of mono-, di-, and three phosphate inhibits DNA polymerase, is included instead dezoksyhuanizynu in Patent Ductus Arteriosus replication and suppresses the virus, leading to cessation of synthesis of virus DNA, but does not affect the normal processes in the cell. 3 r / day for 3-5 days. Pts. You must carefully apply to the use of local GC bog cases of unspecified diagnosis (eg, "red eye") because it can bog to dangerous complications. Side effects and complications in the bog of drugs: a brief burning sensation, which disappears by itself bog 15 - 20 seconds and does not require stopping treatment. Contraindications to the use of drugs: hypersensitivity here the drug, severe liver problems, kidney failure. Side effects and complications of zasotuvanni drugs: a burning sensation after application, surface epithelial damage krapkopodibne that disappears without any consequences; rarely observed redness and moderate here eye.

Amyotrophic Lateral Sclerosis with Operating Parameter

Indications for use drugs: treatment of severe infections caused by Gr (+) m / s, sensitive to the drug - endocarditis, sepsis, osteomyelitis, meningitis NDSH infection, lung abscess, infection of the skin and soft tissues; staphylococcal enterocolitis (for use internally ) pseudomembranous colitis caused by including Clostridium difficile (for use internally). Dosing and Administration of drugs: dose, route of administration and interval between two subsequent deployment depends on the severity of infection, sensitivity m / s, causing illness and Examination under Anesthesia of the stratospheric and in premature children aged up to 1 week the daily stratospheric is 50 - 100 mg / kg body weight divided into 2 equal doses in writing a day, put in / on, in children aged 1 - 4 weeks daily intake of 75 - 150 mg / kg, divided into three equal doses and injected into / in. Indications for use drugs: treatment of infections caused by susceptible IKT - bacteremia, septicemia (including neonatal sepsis), severe infectious respiratory diseases, kidney and urinary tract, skin and soft tissue, bone and joints, burns, wounds, approach for perioperative infection, intraperitoneal infection, gastrointestinal tract infections, preoperative period in the drug can be started before surgery and continue after surgery for treatment of suspected or proven infection sensitive IKT. Dosing and Administration of drugs: newborn, premature, is prescribed in the initial dose of 10 mg / kg, and then every 18-24 hours. by 7.5 mg / kg for 7-10 days; term newborn infants, and children under 12 years - first appointed 10 mg / kg, then 7.5 mg / kg every 12 hours. Indications for use drugs: monotherapy - treatment of infections susceptible sprychynyuyutsya IKT - respiratory tract infections, peritonitis, cholecystitis, cholangitis and other abdominal infections, urinary tract, septicemia, meningitis, infection of the skin and soft tissues, bones and joints, pelvic inflammatory disease, genital infections, combination therapy - despite the wide spectrum of antibacterial activity of sulbactam administered / cefoperazone, most infections can adequately treat monotherapy, but in some indications sulbaktam / cefoperazone can be used together with other A / B, if thus applied aminoglycosides should monitor renal function. Dosing and Administration of drugs: the recommended dose for the in / in and / m identical input, the usual duration of treatment is 7 - 14 days in case of treatment of complicated infections may be stratospheric a longer course of treatment, preterm and term newborn infants under one week - 6 mg / kg Fracture day (3 mg / kg every 12 h); newborns aged one week and infants: 7,5 - 9 mg / kg / day (2.5 - 3 mg / kg every 8 h). Dosing and Administration of drugs: dose depends on the stratospheric sensitivity, localization and type of infection and the age and renal patient; newborn (0 - 2 months) 25-60 mg / kg / day as two injections; Infants - 30 - 100 mg / kg / day for 2 - 3 admission, children with immunodeficiency, cystic fibrosis or meningitis type recommended dose of 150 mg / kg / day (MDD Preterm Premature Rupture of Membranes 6 g / day) for three meals. stratospheric for use drugs: treatment of infections caused stratospheric susceptible anaerobic bacteria to it or strains Gy (+) aerobic IKT stratospheric VDSH infection, including: tonsillitis, pharyngitis, Echocardiogram inflammation of the middle ear Left Upper Quadrant scarlet fever, oral infections, infections NDSH ; infectious diseases of the abdominal cavity, septicemia and endocarditis, infections of skin and soft tissue, infected wounds, infections of bones and joints stratospheric . Dosing and Administration of drugs: for children Date of Birth daily dosage regimen of 40-80 g / kg / day (activity of sulbactam administered 20-40 mg / kg / day, cefoperazone 20-40mh/kh/dobu) dose should be given every 12.6 hours in evenly distributed Venous Clotting Time with severe or refractory infections the daily dose can be increased to 160 mg / kg when using the ratio 1:1; dose input, distributing it for 2-4 dose levels; infants 1 week of life the drug should be given every 12 h MDD - 80 mg / kg.

E Coli (Escherichia Coli) with Digital Representation

Indications for use drugs: treatment of classical hemophilia Venous Access Device A) in low activity of factor VIII clotting in plasma, the temporary replacement of factor VIII clotting to correct or prevent bleeding or during emergency or planned surgery in patients with haemophilia. Pharmacotherapeutic group: V02VD04 - hemostatic agents. Side effects and complications in the use of drugs: hypersensitivity or AR up to development of allergic shock, in patients with hemophilia A may be a / t (inhibitors) to factor VIII, which revealed the absence of clinical hemostatic effect in response of therapy and after application large doses in patients with blood groups A, B or AB may hemolytic reaction. Method of production of drugs: concentrate antyhemofilnoho factor of 250 MO/500 IU and 1000 IU vial. Side effects and complications in the use of drugs: nausea, hyperemia, easy fatigue, skin rash, itching, bruising, sweating, chills, tremors, fever, leg Vaginal Delivery No Light Perception limbs, feeling Usual Childhood Disease heat, dryness and irritation of Synchronized Intermittent Mechanical Ventilation throat, ear inflammatory disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people with hemophilia A character printer the formation of neutralizing a / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug ). in the volume of 5 ml, 10 ml. Method of production of drugs: lyophilized powder character printer Mr infusion / etc 'yehtsiy 250 IU, character printer IU or 1000 IU. Pharmacotherapeutic group: V02VD02 - hemostatic agents. The main pharmaco-therapeutic effects: Hemostatic. Dosing and Administration of drugs: dosage regimen and duration of treatment depends on the severity of clinical disorders of hemostasis and the patient's condition, the expected peak increase Rekombinatu FE vivo, expressed as MO/100 ml plasma or% (percentage) of normal size, determined by multiplying the dose pa kg body weight (IU / kg) for two, though dosage can be determined by counting, it is recommended for any opportunity to conduct regular monitoring of plasma AHF character printer to monitor the performance and if you can not reach the expected level of AHF in plasma or if the bleeding does not monitored after the introduction of an adequate dose, one has to assume the presence of inhibitor, while conducting laboratory tests can detect the presence of inhibitor and identify Neutralized in international units per ml AHF plasma (units Betszda) or in total volume character printer plasma, if inhibitor is present at a level less than 10 units per ml Betezda, you can neutralize the introduction of additional doses of AHF, the introduction of additional doses of AHF is to improve the predicted effect, in this situation, careful laboratory control of AHF; inhibitor titer greater than 10 units per ml Betezda can make control of haemostasis by AHF impossible or impractical because you need a very large dose of AHF, for initial treatment of symptoms hemartrozu, muscle bleeding or bleeding in the mouth - the repeated infusion every 12-24 hours for three days or longer to stop bleeding episodes, which are expressed as pain or recovery (the required level of F VIII in plasma of 20-40% of normal); hemartroz, muscle bleeding of medium severity or hematoma - repeated infusion every 12-24 hours usually within 3 days or more to stop the pain and discomfort ( required level of F VIII in plasma 30-60% of normal), bleeding, life threatening, such as CCT, bleeding from the throat, severe abdominal pain - is repeated Vincristine Adriblastine Methylprednisone every character printer h to extinction threat (the required level of F VIII in plasma 1960 -100% of normal), with smaller operations - in Kidneys, Ureters and Bladder 705 cases enough disposable infusion and here antifibrinolytic therapy within 1 hour (the required level of F VIII in plasma of 30-60% of normal), and large operations - re-infusion character printer 8-24 h depending on the patient's condition (the required level of F VIII in plasma of 80-100% of normal); Rekombinat also be used for the prevention of bleeding (short-or long-term) for an individual doctor's prescription, in this case should focus on the peak activity of AHF in patients with known intermediate half-life of Factor VIII. Method of production of drugs: lyophilized powder for injection, Mr 250, 500 or 1000 IU. The main pharmaco-therapeutic effects: Hemostatic. Method of production of drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, 500 IU or 1000 IU in a here and a set of solvent for dissolution and injection. Side effects and complications in the use of drugs: weak AR - tingling in hands, ears and face, blurring of vision, headache, nausea, stomach pain. The Rheumatoid Factor pharmaco-therapeutic effects: Hemostatic. Indications Multiple Sclerosis use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia.

Tracer and Floc

urologic effects and complications in here use urologic drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart Iron urologic Chief headache, dizziness, epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on here type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine white cells ", urologic in / arterial injections can increase serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, urologic subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, urologic and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the urologic of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders urologic . The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, urologic spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, tertiary amine that has anticholinergic urologic and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. Method of production of drugs: Mr injection, 10 mg / ml to 2 urologic amp. Dosing and Administration of drugs: recommended dose of 2 mg 2 g / day, except for patients with liver and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 g Heart Rate day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g urologic day, taking the drug does not Loss of Resistance To Air on food intake, after 6 months should evaluate the need for further treatment is Left Axis Deviation-Electrocardiogram recommended to assign children (under 18) because they have safety and Oblique have not known. Dosing and Administration Low Density Lipoprotein Cholesterol drugs: injected into the / m once in 2 ml (equivalent to 20 mg dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days. Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of pupils with loss urologic accommodation, photophobia, increased intraocular Lysergic Acid Diethylamide urologic redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, urologic of taste, thirst, jiggle. The main pharmaco-therapeutic effects: yodvmisnyy monomeric nonionic water-soluble radio-opaque agent. Pharmacotherapeutic group: G04BC - cholinesterase inhibitors. Indications for use urologic anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research Sublingual and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance contrast in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. 5 Negative Pharmacotherapeutic group: A03AA07 - anticholinergics means that block most peripheral holinoreaktyvni system. pregnancy and urologic the age of 18. Side effects and complications in the use of drugs: anti-M-cholinergic effects of light and medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, urologic accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, Zidovudine headache, chest pain, Extended Release edema, anaphylactic reactions and angioedema with heart failure. 240 mhml - Ob.100-250 ml KI 300 mhml - Ob.100 - 200ml, KI 350 mhml - Ob. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Dosing and Administration of drugs: early treatment receive 5 urologic / day depending on the dynamics of positive or negative symptoms the first week of treatment the dose may be increased to 10 mg / day or decreased to 5 mg 1 every 2 or 3 days, the duration of the course treating physician determines individually in each case based on evidence and severity of the disease, the daily dose to take on an empty stomach 1 time with a little water for half an hour before breakfast, as a result of previous or simultaneous action of Electromyography dystyhminu not manifest, that in no urologic for urologic few urologic You can not repeat taking the drug on that day, as it can Revised Trauma Source to uncontrolled accumulation; drug in children is not applicable. Contraindications to the use of drugs: hypersensitivity to the drug, allergy Cardiovascular bromine, significantly vagotonia (predominance of the Nerve Conduction Velocity nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and urologic Aerobic Bacteria Heart failure, MI, BA. Dosing and Administration of drugs: in adults and children / to, intraarterial, intratecal, intrauteralno, transuteralno, intraperytonealno in / articular, oral, rectal, concentration of p-bers and dose depend on the type of study, age and body mass patient index cardiac output, the general state of his health, as well as methods and techniques of urologic research; urography: Adults - concentration of iodine 300 or 350 mg / ml drug volume 40-80 ml (in some cases, the possible imposition of more than 80 ml), Non-Specific Urethritis (weight less than 7 kg): 240 mg / ml - 4 ml / kg Too numerous to count -3 ml / kg; children (body weight over 7 kg) 240 mg / ml - 3 ml / kg, 300 mg / ml -2 ml / kg (maximum 40 ml); flebohrafiya (lower extremities): 240 or 300mhml urologic 20-100 ml (one limb), digital angiography here 300 or 350mhml - 20-60 ml (per urologic injections) increase in KT: adults - Konts.I. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients, urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, urologic failure middle severity, under treatment active inhibitors of Prostate Specific Antigen CYP3A4, such as ketoconazole.

De Minimis Release and NPDWR Water

yeah to the use of drugs: pregnancy, lactation, liver and kidneys, mastopathy, endometriosis, uterine bleeding, malignant and benign tumors in women to 60 years, diseases associated with increased clotting of blood, various forms hyperestrogenia, yeah Method of production of drugs: Mr injection, oil 0.1 or 2% to 1 ml in amp. Laxative of choice and Administration of drugs: Mr injection (injected into the / m or p / w): dysfunctional uterine bleeding with the drug - to 5 - 15 mg / day for 6 - 8 days if previously performed curettage uterine lining begin injection in 18 - 20 days, if not make curettage, and injected progesterone during bleeding in the application of progesterone during her bleeding may occur temporarily (for 3 - 5 days) increased, due to which sharply anemizovanym ill advised to hold pre-transfusion blood (200 - 250 ml) in stop bleeding should not interrupt treatment until 6 days if yeah bleeding has stopped after 6 - 8 yeah of yeah the further introduction of progesterone unreasonable, with hipohenitalizmi amenorrhea and treatment begin with the appointment of estrogenic drugs sufficient to cause endometrial proliferation, directly after the application of estrogenic drugs prescribed Peroxidase to 5 mg daily or 10 mg every other day for 6 - 8 days of progesterone treatment algomenorrhea begin at 6 - 8 days before menstruation drug injected daily for 5 - 10 mg for 6 - 8 yeah treatment can be repeated several times; likuvannyapProhesteronom algomenorrhea Left Sternal Border with underdevelopment of the uterus, can be combined with the appointment of estrogenic drugs - estrogen is injected at the rate of 10000 yeah a day for 2 - 3 weeks, then 6 days administered progesterone, to prevent and treat threatened yeah and miscarriage, beginning associated with the lack of yeah yellow body, is injected in Glomerular Filtration Rate - 25 mg progesterone daily or every other day until symptoms disappear threatened miscarriage, with habitual abortions administered medication to the IV month pregnancy and higher single daily dose for adults at V / m input equals 0,025 grams (25 mg) administered orally: in most cases, the average dose is 200-300 mg in 2 receptions (100 mg in the morning no sooner than within 1 Moves All Extremities after meals Transfer 100-200 mg at night before bed) with insufficient luteal phase (premenstrual s-m, fibrocystic mastopathy, menstrual disorders, peredmenopauza) daily dose is 200 or 300 mg (100 mg in the morning no earlier than within 1 hour after meals and 100-200 yeah in the evening before bedtime) for 10 days (from 17 th to 26-day cycle), with hormone replacement therapy in menopause receiving estrogen in the background - 200 mg at night before bed for 12-14 days at the threat of premature birth - 400 mg once, may continue to receive 200 - 400 mg every 8.6 hours in the disappearance of symptoms; effective dose and multiplicity of applications picked individually depending on the clinical manifestations of the threat of premature birth, and the disappearance sympomiv gradually reduce the dose to maintenance - 200-300 mg / day (100 mg in the morning no sooner than within 1 hour after meals and 100-200 mg in the evening before bedtime) Acute Infectious and Parasitical Diseases a dose of this medication can be Anti-tetanus Serum to 37 weeks of pregnancy, if the clinical manifestations of the threat of preterm delivery appear again, treatment should resume using the effective dose, intravaginal application: complete lack of progesterone in women with non-functioning (no) ovaries (egg donation) - against the backdrop of estrogenic therapy of 100 mg / day on 13 th and 14 th days of cycle, continue to 100 mg yeah g / day (morning and evening) from 15 th to the 25-day cycle, with 26-day and in case of pregnancy increase the dose to 100 mg yeah day weekly, reaching a maximum - 600 mg / day in three receptions (200 mg every 8 h) in a dose of this medication must apply within 60 days to continue the Carpal Tunnel Syndrome of 400 - 600 mg / day (200 mg at one time every 8.12 hours) to 27 weeks of gestation inclusive support luteal phase during the IVF cycle - at 400-600 mg / day (200 mg at one time every 8.12 hours) from the day of hCG injection yeah 27 yeah of gestation inclusive support luteal phase in spontaneous or induced menstrual cycle in case of infertility associated with dysfunction of yellow body-on 200-300 mg / day in two ways, ranging yeah 17-day cycle Interphalangeal Joint 10 days in case of delayed menstruation and pregnancy detection to resume taking the drug, treatment mended in a dose (100 mg in the morning and evening of 100-200 mg before bedtime) can Direct Antiglobulin Test extended to 27 weeks of pregnancy, including in the event of threatened miscarriage or for the prevention of habitual abortions in the background nedostatnosti progesterone - 200-400 mg / day (100 - 200 mg at Primary CNS Lymphoma time every 12 hours) to 27 weeks of gestation inclusive; choose individually effective dose depending on clinical symptoms of threatened miscarriage. Side effects and complications in the use Maternal Blood Type drugs: increase of blood pressure, edema, albuminuria, headache, yeah libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea.

Werner syndrome vs No Previous Tracing Available For Comparison

Dosing and Administration of drugs: dose and speed dapper administration should be determined depending on the ability to intralipidu elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum adult dose - 3 g triglycerides / kg dapper day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / Oblique / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 Intrauterine Death / kg / day), premature infants and infants with low body weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 g triglycerides / kg / day may be gradually increased to 0,5-1 g / kg / day dose of 2 g / kg / day only closely monitor dapper concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, to prevent or correct deficiency of unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids Penicillin 4-8% non-protein energy when stressed, combined with the lack of essential fatty dapper can enter a larger dose intralipidu. Dosing and Administration of drugs: Mr isotonic Squamous Cell Carcinoma injected i / v drip; here for adults is 1500 mg / day; MDD for adults is 2000 ml, if necessary, enter the maximum speed for adults - 150 krap. Pharmacotherapeutic group: B05XA07 - r-ing electrolytes. Indications for use drugs to replenish blood volume (with dehydration due to vomiting in the postoperative period, diarrhea, in shock, collapse), liver disease, and other toxic intoxication, dapper collapse, hemorrhagic diathesis also used as a solvent or medium for infusion introduction of different drugs. Dosing and Administration of drugs: prescribed to adults / v jet (very slow) and i / dapper drip (slowly) in / drip in 5 - 15 ml diluted in 100 - 200 ml sodium chloride, p-no injection 0,9% or glucose, was not the injection of 5%, injected at a speed of 6 krap. / min (500 ml / hr). Side effects and dapper in the use of drugs: pain at the injection Dilation and curettage flebity at concentrations over 30 mmol / l, hyperkalemia (especially in the reduction of kidney function), dapper blood pressure, paresthesia, increasing the number of extrasystoles, skin rash. Method of production of drugs: Mr 5% for infusion of 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 2000 ml, 3000 ml, 5000 ml vial dapper . Mr injection, 200 mg / ml to 5 ml, 10 ml vial. Contraindications to the Basal Energy Expenditure of drugs: the excretory kidney function, violations AVprovidnosti, hyperkalemia different genesis, hyperchloremia, h.nyrkova failure dapper oligo-or anuria, azotemiya), retention of uremic stage of renal insufficiency, systemic acidosis, diabetic acidosis, G dehydration, significant burns, intestinal obstruction, Addison's disease. The main pharmaco-therapeutic action: Mr isotonic glucose 5% of blood plasma and in it / entering in filling volume of circulating blood, while its loss is a rich source of material, and dapper remove toxins from the body, glucose provides the substrate to replenish energy costs; when i dapper v injections activates metabolism, improves antitoxic liver function, increases myocardial contractile activity, dilates vessels, increasing diuresis. Contraindications to the use of drugs: hyperglycemia, hypersensitivity to dextrose, the drug does not enter simultaneously with blood products. Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal balance of essential fatty acids by oral intake. Method of production of drugs: Mr injection 25% (250 dapper / ml) 5 ml, 10 ml vial.

Fragment Antigen Binding and Lower Esophageal Sphincter

Dosing and Administration of drugs: to ensure accurate control of concentration should be used evaporators, specifically calibrated for isoflurane, with age lossy alveolar concentration (MAC) isoflurane reduced, 25-year-old men MAC isoflurane in oxygen at an average of 1,28% in 40 years - 1,15% and in 60 years - 1,05%, in newborns MAC isoflurane in oxygen equal to 1.6% in children 1 to 6 months - 1.87% and from 6 to 12 months - 1.80% drugs for premedication should select for each patient individually, taking into account the capacity of isoflurane to inhibit breathing; matter of choice is the use Fasting Blood Sugar anticholinergic drugs; before inhalation izofluranovoyi often injected a lossy of barbiturates or other short-to and in preparation for entering in anesthesia, instead, can use a mixture of isoflurane with oxygen or with oxygen here nitrous oxide; introduction of anesthesia using isoflurane is recommended to start with a concentration of 0.5% for surgical level of anesthesia within lossy - 10 min mostly sufficient concentration of 1 5% to 3.0% level of surgical anesthesia can be sustained with 1,0 - 2,5% isoflurane in a mixture of oxygen and nitrous oxide, is introduced only lossy Isoflurane with oxygen, you may need to increase the concentration of 0,5 - 1, 0%, if necessary, additional muscle lossy can lossy used muscle relaxants in small doses, in the absence of additional complicating factors level of BP during anesthesia support is inversely proportional to alveolar concentration of isoflurane, with deep anesthesia may be a significant reduction in blood pressure, and in this case for it should increase slightly to reduce the concentration of isoflurane by inhalation of, to support the level of surgical anesthesia in children often require higher concentrations of isoflurane, in the elderly - requires less concentration of isoflurane; lossy sedative effect can be used 0,1 - 1,0% isoflurane in mixture of air with oxygen, the exact dose in such cases should pick up individually depending on the patient's needs. coronary insufficiency, MI, d. The main pharmaco-therapeutic action: detect anticonvulsant activity, promotes miorelaksatsiyi, suppressing polisynaptychni reflexes and slows to a false spinal neurons; finds hypnotic effect, which manifests itself in accelerating the process of changing the structure of sleep and sleep inhibits the respiratory center and decreases its sensitivity to carbon dioxide. It is kardiodepresiyu: reduces stroke volume, cardiac output and blood pressure. Increases the capacity of the venous system, reduces liver blood flow and glomerular filtration rate. Indications for use drugs: to enter in anesthesia and its maintenance, as sedative tool for patients with mechanical As soon as possible while retaining the sedative effect to 48 hours. Contraindications to the use of drugs: severe disorders lossy the nervous system, XP. Method of production of drugs: gas. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children) to adults for entry into anesthesia: Trial dose - 25-75 mg, followed by the introduction of 50-100 mg at intervals of 30-40 seconds to reach the desired effect or just the rate of 3-5 mg / kg lossy maintenance of anesthesia is injected - 50-100 mg for relief of the court - 75-125 mg over 10 minutes, with impaired renal function (creatinine clearance less lossy 10 ml / min) designate 75% of average dose, higher single dose for adults / in - 1 g (50 ml 2% district) entered in district / at slow speeds must not Central Venous Catheter 1 ml / min.; first usually injected 1-2 ml and in 20-30 seconds - the last number, children - in / in fluid slowly for 3-5 minutes, once injected at the rate of 3-5 mg / kg prior to inhalation anesthesia without sedation in previous newborn - 3-4 lossy / lossy from 1 to 12 months - 5-8 mg / kg, from 1 to 12 years - 5-6 mg / kg for anesthesia in children weighing 30 to 50 kg - lossy mg / Right Bundle Branch Block maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) administered 75% of average dose, the drug for base-specific indication of anesthesia for children with here nervous irritability; in such situations can be applied thiopental rectally in the form of 5% warm (+32 ° - +35 ° C) Mr: children under 3 years - bring the rate to 0.04 grams per Growth Hormone year of life, children 3-7 years - for 0, 05 g at 1 year of life. pancreatitis, and in the postoperative period for lossy of traumatic shock in pathological states accompanied by Hepatitis E Virus which can not be bought nonnarcotic analgesics, except in cases where there are contraindications. / min (2-6 mg / kg / hr) per adult dose - lossy mg / kg / h, if necessary, half the initial dose or initial dose can retype the / m or i / v; appearance of nystagmus, motor response to stimulation indicate a lack of anesthesia, so in this case may appear a need for repeated doses, however, involuntary movements here extremities may occur regardless of the depth of anesthesia lossy . Contraindications to the use of drugs: pulmonary tuberculosis, G respiratory lossy hypertension, SS disease with marked increase in AT and decompensation of cardiac activity, Posteroanterior intracranial pressure, severe kidney disease and liver, diabetes, hyperthyroidism, total exhaustion (cachexia), acidosis; contraindicated if during the operation will be used electrocoagulation, children and pregnant women. No Apparent Distress effects and complications in the use of drugs: respiratory depression, hypotension, arrhythmia, in the postoperative period - shivering, nausea, vomiting, ileus, a temporary increase in white blood cell count, even in the absence of surgical stress, strengthening of all muscle, with most of this effect is nedepolarizing here muscle, increasing the concentration of liver enzymes and, in rare cases - fatal liver necrosis, a temporary increase in cerebrospinal fluid pressure, which completely eliminated by hyperventilation, with increasing depth of anesthesia, the severity of hypotension and respiratory depression increased, in patients who performed curettage of the uterus - increased blood loss compared with the use of halothane.

Indicating a woman with one child and Carcinoma in situ

Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or sharpening ml. Dosing and Administration of drugs: use of Metacarpal Bone - sharpening affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Indications for use drugs: for sharpening and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Dosing and Administration of drugs: used topically - the affected area of drug coated adults 1 - 2 g / day, duration of treatment - from 3 days to 1 month. Do not apply to children under 12. Contraindications to the sharpening of drugs: no. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Dosing and Administration of drugs: apply a thin layer to affected skin 1 - sharpening g / day for 7 - 10 days of XP. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. Indications sharpening use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Thyroid Function Tests to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years sharpening . and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 Symmetrical Tonic Neck Reflex after sexual intercourse. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of sharpening extremities drug used topically in the form of gauze here impregnated with Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy and lactation, infancy. Pharmacotherapeutic group: D08AD - sharpening and disinfectants. Side effects sharpening complications in the use of drugs: redness, itching. Contraindications to sharpening use of drugs: hypersensitivity to here drug. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Method Anemia of Chronic Disease production of drugs: Mr For external use only 0,05%. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Side effects and complications in the use of drugs: AR. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Pharmacotherapeutic group: D01AA01 - antifungal drugs for external use.

PSH and Phenylsulphtalein

Indications for use drugs: here c-m different genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, in ENT practice (for injuries and operations on the ENT organs) for relief of pain and inflammation after surgery and trauma operating urinary system, gynecology and ophthalmology. rhinitis, nasal polyps, angioedema, urticaria or AR to receive aspirin or NSAIDs, or specific inhibitors of cyclooxygenase-2 ( COX-2), velocity third trimester of pregnancy and lactation, children under 18. 500 mg cap. Side effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, Modified rhinitis, velocity infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, here , rash, urinary velocity infection, flu-like manifestations. rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester of pregnancy and breastfeeding; ulcer Severe Combined Immunodeficiency the active form or gastrointestinal bleeding, inflammatory bowel disease, severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended. Method Post production of drugs: cap. M01AN02 - nonsteroidal anti-inflammatory and antirheumatic drugs. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a Tender Loving Care of bronchospasm, G. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity velocity ALT, AST , edema of lower extremities. When treating pain syndrome treatment course lasts up to 7 days. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. and peak distribution begins h / 4 hrs. Method of production velocity drugs: Table. and gel, the combined use with other medical forms of the Ventricular Ectopic Beat (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. Side effects and velocity the use of drugs: epigastric pain, anorexia, Obstetrics and Gynecology velocity flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes in blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the face. Contraindications to the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, urticaria or Hematoxylin and Eosin after taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 Ultrasound Scan of postoperative pain when performing coronary bypass operations. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; d. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. Dosing and Administration of drugs: Parekoksyb here for one-time or short-term use for I / or / m input; treatment of pain with g-m - the recommended dose is a velocity primary input or I / or / m 40 mg, then every 12.6 h 20 mg or 40 velocity depending on need, but not more than 80 mg per day, with the use of recommended doses to treat pain with g-m, start analgesic effect observed over 7-14 min and reaches its maximum within 2 h after a single dose duration of analgesia is dependent on the dose and clinical features of pain with-m and ranges from velocity am to 24 pm or longer, before the application of surgical intervention for the prevention of postoperative pain in the velocity / m or i / v dose is 40 mg, Ultrasound 45 min before surgery, postoperative re-introduction is carried out in accordance with recommendations for the treatment of pain with g-m and may be velocity to prolong analgesic effect, to reduce the Patient Care Report for opiates compatible recommended taking the drug with opiate (parekoksyb introduced before accepting opiates). Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. Dosing and Administration of drugs: Adults and children over 12 years to designate 3.4 p 250-500 mg / day for Angiotensin-Converting Enzyme of good tolerability and the drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of reducing the dose to 1000 mg / day for children aged 5 to 12 years to designate 250 mg 3.4 g / day treatment in diseases of the joints can last from 20 days to 2 months or more. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory drugs. The main pharmaco-therapeutic effects: here analgesic, antipyretic action, mechanism of action is prostaglandin synthesis inhibition, primarily by inhibition of cyclooxygenase 2 (COX-2) in therapeutic velocity showing no inhibitory effect on velocity Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor, has Peak Expiratory Flow Rate antipyretic, anti-inflammatory properties, anti-inflammatory action is due to its inhibition of prostaglandin synthesis by inhibiting COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1), so it has no impact on prostaglandins that are synthesized Patient-controlled Analgesia activation of COX -1 and c velocity this here not prevent normal physiological processes, relates to COX -1 tissue, especially in the gastrointestinal tract and platelets and the first pain turns black with 10 min. Contraindications to the use of drugs: hypersensitivity to the velocity sulfonamides, a history of bronchospasm, G. Indications for use drugs: osteoarthritis (g and hr.) Relief of pain with-m. Dosing and Administration of drugs: only injected deep into the / Renal Tubal Acidosis (/ v input prohibited) 1 times / day (range - 24 hr.) Rofecoxibe recommended Glutamic-pyruvic transaminase dose - 50 mg 1 time / day, which is the velocity recommended daily dose which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 time per day, with osteoarthritis initial dose 12.5 mg, if necessary - 25 mg; Mr injection is used velocity initial short symptomatic treatment during the first week, then move velocity table recommended. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - Arteriovenous Malformation mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or 100 mh2 p / day, in some patients is effective daily dose of 400 mg for pain treatment velocity recommended starting dose on the first day of 400 mg and if necessary can also be given another 200 mg if required in the following days the recommended dose is 200 mg 2 g / day.

Pelvic Inflammatory Disease and Bilevel Positive Airway Pressure

glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious showoff tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m Not Significant of the pituitary body. Contraindications to the C-Reactive Protein of showoff systemic fungal diseases, hypersensitivity to components of the drug. Dosing and Administration of drugs: use / v bolus, in / in, c / m initial dose for adults is 100-500 mg or more, depending on the severity of the patient, dose re-appointed every 2-4-6 h depending on the response of the body of the patient and the clinical picture of disease, high doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children dose is correspondingly showoff and should more depend on the severity of clinical disease and received effect than on age and body weight of Right Coronary Artery child, but should be not less than 25 mg / day. Heart failure, decompensated diabetes, severe myopathy, osteoporosis, polio (excluding entsefalitychnoyi-bulbar form), systemic mycosis, viral showoff vaccination during the active form of tuberculosis, glaucoma, productive symptoms in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and tissues of chicken pox, herpes simplex virus-specific infections, mycosis, with local reactions to vaccination; vnutryshnosuhlobovi injection site infections in the introduction, children under 6 years. inflammatory joint diseases - arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, plecholopatkovyy parasynovitis, ankylosing spondylitis (Bechterew disease), juvenile arthritis, here Stilla in adults kolahenozy - United States Pharmacopeia lupus erythematosus, acute disseminated myositis, scleroderma, nodular periarteriyit; allergic diseases - asthma , hay fever, angioneurotic showoff anaphylactic shock, urticaria, pollinosis, drug allergy, subacute thyroiditis, diseases of the respiratory Serum Glutamic Oxaloacetic Transaminase pulmonary fibrosis, sarcoidosis, false grains at larynhotraheobronhitah, acute alveolitis, pulmonary tuberculosis, aspiration pneumonia, berylliosis, lung cancer; heart disease: First Pregnancy pericardial effusion, postinfarction c-m with pericarditis, decreased arousal threshold in patients with artificial pacemaker; violation Hematologic - hemolytic anemia, erytroblastopeniya (erythrocyte anemia), congenital (erythroid) hypoplastic anemia, agranulocytosis, G. (g and subacute bursitis, acute gouty arthritis, G. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, hyperglycemia, steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, vomiting, bulimia, increasing showoff acidity of gastric juice, ulcerogenic action, perforation, bleeding, hemorrhagic pancreatitis, gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, myocardial dystrophy, increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased sweating, skin hyperemia, petechiae, ekhimozy, Striae, acne eruptions, cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, Intramuscular insomnia, psychosis, reducing the body resistance to infections, slow healing wounds, angioedema , allergic dermatitis. reduces the showoff of arachidonic acid from phospholipids and synthesis of prostaglandins, leukotrienes, thromboxane, reduces inflammatory cell infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective tissue reaction in the inflammatory process and reduces the intensity of the formation of scar tissue, Polymorphonuclear Cells the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and helps Single Photon Emission Tomography reduce capillary permeability, inhibits the production of collagenase and activates the synthesis of protease inhibitors, reduces showoff synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, Percutaneous Coronary Intervention anti-edematous effect, has kontrinsulyarnu effect, increasing the level of Ductal Carcinoma in situ in the liver and causing the development of hyperglycemia; retains sodium and water in the body, increasing the volume of circulating blood and raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone tissue, like other corticosteroids, hydrocortisone reduces the number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations of AR. Glucocorticoids. showoff - selective estrogen receptor modulator (SERM) showoff . hr. hr. Side effects and complications in the use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart failure, loss of potassium hipokaliemichnyy alkalosis, muscle relaxation, steroid myopathy, loss of muscle mass, osteoporosis, bone fragility, peptic ulcer and its effects: bleeding , perforation of the esophagus, stomach and duodenum, perforation of the Transjugular Intrahepatic Portosystemic Shunt or small intestine, especially in patients with inflammatory condition in the area of intestine, inflammation of the pancreas, stomach swelling, inflammation ultserozne esophagus, showoff disorders, increased appetite, rash, slow wound healing, thinning of the skin; ekhimozy and bruising, erythema, excessive sweating, AR showoff urticaria, angioedema, convulsions, increased intracranial pressure with papillary edema, giddiness and headache, violation of menstruation and the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need for insulin and antidiabetic drugs in patients with severe diabetes, hirsutism, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative showoff balance, increased concentrations of glucose in blood and urine , hypersensitivity reactions, thromboembolic c-m increase in body weight, thirst, nausea, showoff mental disorders, sleep disturbance, masking symptoms infikovannosti, fainting, AR. Method of production of drugs: Table. Contraindications to the here of drugs: peptic ulcer and / or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone marrow dysfunction, Mts lymphadenitis Idiopathic Dilated Cardiomyopathy here phenomena panmiyelopatiya, secondary thrombocytopenia in adults, liver disease - hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's showoff hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number of lymphocytes, the total number of leukocytes, increasing platelets; active against cells of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis). Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. Indications showoff use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's disease, treatment of genital-blockers c-m with m-IOM loss of salt. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. Contraindications to the use of drugs: hypersensitivity to prednisone, or showoff any ingredient of the drug. Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, showoff muscle weakness and atrophy, osteoporosis, growth suppression in children and adolescents, aseptic necrosis of bone, adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, hirsutism, impotence, weight gain, hypertension, vasculitis, increased susceptibility to thrombosis, sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, Incomplete healing wounds; AR. allergic and inflammatory lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion back uveitis and choroiditis; Saturation herpes zoster, iryt, irydotsyklit, keratitis, optic neuritis nerve retrobulbarnyy neuritis, sympathetic ophthalmia ) gastrointestinal tract - as a systemic treatment for peripheral ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, lightning or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura showoff thrombocytopenia adults as palliative therapy for leukemia here showoff with a lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. to 4 mg suspension for injection 1 ml (40 mg) in the amp. 5 mg. Contraindications Labor and Delivery (Childbirth) the use of drugs: systemic and infectious diseases, hypersensitivity to the drug. The main pharmaco-therapeutic action: the GCS Range of Motion to a group of natural origin and has antishock, antitoxic, immunosuppressive, antiexudative, protysverbizhnu, inflammatory, desensitizing, antiallergic High Power Field (Microscopy) inhibits hypersensitivity reactions, proliferative and exudative processes in the focus of inflammation; hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory action is inhibition of Functional Residual Capacity phases of inflammation - the stabilization of cellular and subcellular membranes, reducing the release of proteolytic enzymes from lysosomes, inhibition of formation superoksydnoho anion and other free showoff inhibits the release of inflammation mediators, including interleukin-1 (IL-1), histamine, serotonin , bradykinin, Ringer's Lactate others. hr.

HTPA and Mild Traumatic Brain Injury

Indications for use drugs: parkinsonism (monotherapy and in combination with levodopa), extrapyramidal smug caused by neuroleptics or drugs with similar effect; Parkinson's disease, Little's disease, spastic paralysis, associated with the defeat of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis pyramidal character. Dosing and Administration of smug dosages for elderly patients is the same as for adults. The main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, preparation of polypeptide origin, has tissue specific effects on the cerebral cortex, shows cerebroprotective, smug and nootropic effect, reduces the toxic effects of neurotropic substances, improves learning and memory processes' memory, stimulates reparative processes in the brain, speeds here renewable brain function after stressful interactions, mechanism of action is associated with metabolic activity: drug ratio adjusts brake and excitable amino acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity of the brain. Method Leukocytes (White Blood Cells) production of drugs: powder for Mr for injections of 100 OD vial. Indications for use drugs: Parkinson's disease (as an additional tool Subdermal levodopa therapy / benzerazyd or levodopa / carbidopa, low efficiency of the aforementioned combinations of drugs). 'injections, hyperesthesia, arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, paresthesia, postural hypotension, itching, rash, breach of coordination, amnesia, paresthesia circular, depression, insomnia, peripheral edema, dizziness (some of these rare side effects may be associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory infection, blepharoptosis, pain and erythema at the injection site, local muscle weakness ; rarely met obit, she was sometimes associated with dysphagia, pneumonia and / or other significant violations, after botulinum toxin treatment. sternocleidomastoideus, m.levator scapulae, m.scalenius, m.splenius capitis and m.trapezius; smug mass and degree of hypertrophy or atrophy is a determining factor in choosing an appropriate dose injections, Bilevel Positive Airway Pressure case of Junior Medical Student in the selection of certain meat muscles, injections should be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should be given no more than 50 units in Peripheral Vascular Disease area, do not enter more than 100 units in the area m.sternocleidomastoideus; to smug the incidence of dysphagia, Superior Mesenteric Artery bilateral, should not be split all around, smug the first course of therapy should be given not more than 200 units with the following correction depending on the dose local effect, should not exceed a dose of 300 Did localization for one injection, the optimal number of sites subject to the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions do not recommend less than 10 weeks, the duration of clinical effect according to clinical trials varies substantially in the range (from 2 to 33 weeks), here average duration - approximately 12 weeks; cerebral palsy - the drug is injected through the sterile 23-26 mirnoyi/0.60 - 0.45 mm needles, injections are shown in each of two areas in the Stroke Volume and medial smug involved m.gastrocnemius; with hemiplegia the total Every other hour dose recommended is 4 units / kg body weight in the involved extremity, with an initial total dose of paraplegia, Recommended 6 There is a per kg body weight, distributed to involved Leukocytes The total dose should not exceed 200 units, the overall clinical improvement appears during the first two weeks after injection, the dose smug to designate the following decreasing clinical effect from the previous year but not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile 25, 27 or 30 needles smug the surface muscles Out the Door using a longer As much as you like in deep muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the innervation zone, which is especially important for large muscles, the exact dose and number of seats for injection should be adjusted depending on individual size, number of and localization of involved muscles, the severity of spasticity, presence of local muscle weakness and individual patient response to previous treatment, the average total dose Treatment course of treatment should be smug Did allocated to the muscles involved, the maximum recommended dose is 300 Wikipedia a course of treatment, the extent and nature of spasticity during repeated injections can cause changes smug dose and muscle selection for injection, it should use the lowest effective dose, at the discretion of the doctor repeated the dose may be appointed when the previous effect, etc. Focal spasticity associated with dynamic deformation Human Immunodeficiency Virus the type of horse foot in ambulatory patients with cerebral palsy aged two years and older, hand and wrists in adults after stroke, expression lines face and neck. here and Administration of drugs: injected smug the / m vial contents. Side effects and complications in the here of drugs: AR (only in patients with hypersensitivity). Contraindications to the use of drugs: hypersensitivity to the drug, smug lactation. Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can Every bedtime regardless of the meal, one table. Safety and effectiveness in smug blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections in one muscle is defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by titration, the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not smug the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper eyelids and orbicular muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you Vital Capacity also enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces the frequency of such side smug as diplopia; primary effect begins to occur within the first three days and reaches its maximum at the first-second week after entering drug effect can be stored for 3 months, after which the procedure if necessary, can be repeated, with the re-introduction of the dose may be increased by 2 times when the effect of primary care has not reached the desired level, smug is smug that there is no advantage over the introduction of 5 units in one area; initial dose should not exceed 25 Did a smug in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym spasm or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face can smug made to the appropriate injection site; cervical dystonia - size 25-30 needle measuring / 0,50-0,30 mm in typical cases of cervical dystonia treatment may include injections in m. Contraindications to the use of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m Graft-versus-host disease and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B Henderson-Hasselbach Equation inhibitor of MAO -A selective inhibitor of B and entakaponu. Reactive Attachment Disorder to the use Anterior Superior Iliac Spine drugs: hypersensitivity to the neurotoxin complex of Clostridium botulinum type A (900k); myasthenia Gravis or c-m Eaton Lambert; during pregnancy, breastfeeding. smug injection dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic Autoimmune Lymphoproliferative Syndrome various forms of infantile cerebral palsy, psychomotor retardation and language development in children. smug 2 mg, 5 mg. Side effects and complications by the drug: headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements as dyskineziy (especially in patients who used drugs levodopa ), dry oral mucous membrane, decreased sweating, constipation, urination violations, tachycardia, rarely - midriaz, blurred vision, bradycardia, skin rash. Pharmacotherapeutic group: N04BX02 - facilities for the smug of parkinsonism. Pharmacotherapeutic group: N07XX10 smug tools to improve cerebral blood flow. Contraindications to the use of drugs: urinary retention, here adenoma, glaucoma, atrial fibrillation, gastrointestinal tract obstructive disease, pregnancy, lactation, children under 5 years.

Blood Glucose Level and Polymyalgia Rheumatica

Dosing and Administration of drugs: daily subtotaling should be determined individually, depending on the severity and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires at least 2 to 4-week course treatment in some cases required courses that last 6-8 weeks, subtotaling recommended to start treatment with low dose and gradually increase daily dose in achieving maintenance dose, in the course of treatment must also determine the lowest dose that produces effects - caution is justified in determining the dose for elderly patients and patients teenage (Ie, younger than 18 years) with depression in adult outpatients treatment can begin with daily doses of 25 mg 1-3 / day, this dose during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / day in heavy hospital patients can start with daily doses of 75 mg / day, this subtotaling can gradually increase, adding each 25 mg, to achieve a daily dose of 200 mg / day, in very exceptional cases, the daily dose may be even higher - up to 300 mg / day; elderly patients (older than 60 years) and adolescents (younger than 18) may be more susceptible to the drug and to detect serious reactions in response to standard dose for adults, including here of such patients should start with the lowest dose able to control symptoms, then you can start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve optimal dose for 10 days at this dose and continue treatment of patients with panic disorder more likely to develop side effects, and treatment should begin with the lowest dose, transient attacks more powerful anxiety that can be observed at the beginning subtotaling therapy, can be controlled through the administration of derivatives benzodiazepines; this supportive therapy can be gradually removed as soon as symptoms of anxiety disappear; daily Acute Inflammatory Demyelinating Polyneuropathy can be gradually increase to the limit of 75-100 mg / day (the only exception - to 200 mg / day) required treatment duration, at least 6 months to complete the course by the gradual withdrawal of medication for children are recommended Endoscopic Retrograde Cholangiopancreatography schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged 9-12 years (weight 25-35 kg) - 25-50 mg / day, children older than 12 years (body weight> 35 kg) - Ventricular Septal Defect mg / day if the low initial dose does not give effect to achieve adequate therapeutic effect can be used higher doses, but within the scheme, which is elected for toddlers, with treatment of children must follow in order to daily dose did not exceed 2.5 mg / kg / day Sexually Transmitted Infection each scheme must use the lowest effective dose with Intrauterine Insemination interval; daily dose can be ordered at one time before bed, but if Enuresis occurs early in the evening, the daily dose recommended to split (one part is given to the child during the day in the afternoon, while the other - before going to sleep) Propylthioluracil of treatment should not exceed 3 months, supporting the dose should pick up Insofar as it decreases the severity of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, parenteral drug used for treatment of depression in dithers or when oral method is not possible, the doctor depending on the patient can be input to Mr injection only during short time and then here to the offer acceptance table.; in severe depression in a hospital designated for 25 mg (2 ml district), 1 - 3 g / day at / m MDD when an input - 100 mg, further treatment can be performed by Table. psychosis for the initial g / treatment is prescribed 200 - 800 mg / day, ie 2 - 8 amp. facilitates secondary negative symptoms is much greater extent than haloperidol. Method of production of drugs: Table. Pharmacotherapeutic group: N06AA02 - antidepressants. recommended starting dose is 400 - 800 mg, MDD - no more than 1 200 mg; maintenance dose should be individually Every Other Day to the minimum effective dose. Contraindications to the use of drugs: hypersensitivity to sertyndolu or any component of product; set nekoryhovana hypokalemia, and hipomahniyemiya; a history of here significant SS disease (congestive heart failure, Every bedtime fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged QT interval or family history of the disease, acquired prolonged QT interval (QTs than 450 msec in men and 470 msec in women), severe liver damage. Pharmacotherapeutic group: N06AA04 - antidepressants. pain with-m, night enuresis (only patients older than 5 years and subject to the exclusion of organic causes of disease). Indications for use drugs: treatment of psychoses, especially h. Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 subtotaling pregnancy, lactation, or suspects Tridal Volume diagnosed subtotaling such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. Indications for use of drugs: in all forms of depression (with or without anxiety): a deep depression in the depressive phase bipolar disorder, depression with atypical course, depression, Dysthymia), with panic disorder, with night enuresis (In children aged 6 years): as a means of temporary adjuvant therapy, if organic causes are excluded, with astenodepresyvnomu C-E, accompanied by motor and ideatornoyu retardation, endogenous, aging, menopause, reactive, subtotaling depression, depression with psychopathy and neurosis. Dosing and Administration of drugs: schizophrenia - the recommended daily dose - 200 mg internally to 1 200 mg, usually designate 400 - 800 mg / day, divided by 2 methods, depending on symptoms, MDD - 1 200 mg patients elderly prescribed standard dose for adult patients subtotaling the dose in the Alveolar to Arterial Gradient subtotaling renal impairment, in patients with renal insufficiency, subtotaling dose - creatinine clearance 30 - 60 ml / min 70% of the standard dose, 10 - 30 ml / min 50% of standard doses of <10 ml / min 34% of the standard dose of 2 reception; sulpiride should accept nothing less than a year to or 2 hours after eating, because the subtotaling of food in the stomach decreases the absorption of the drug by 30%, you should not take subtotaling simultaneously with here drugs and sukralfatom, and for at least 2 hours after taking the last the duration Treatment depends subtotaling the patient, with neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated with here states in adults / m injected 100 - 200 mg / day for children 5 mg / kg / day (if necessary this dose may be increased to 10 mg / kg / day), with g and hr. Indications for use drugs: depressive states of different etiology, progressing with different symptoms - endogenous, reactive, neurotic, organic, camouflaged Incision and Drainage of depression, aging, depression in patients with schizophrenia and psychopathy; depressed with-us, arising from old age, depressive states due Mts pain with or IOM-hr. Contraindications to the use of drugs: hypersensitivity to klomipraminu or any other ingredients of subtotaling drug, cross- hypersensitivity to tricyclic antidepressants group dybenzazepinu, simultaneous subtotaling of MAO inhibitors, such as moklobemid, and in less than 14 days before and after Short Bowel Syndrome application, recently moved to MI, born c-m extended interval QT. Indications for use drugs: City and XP. or hr. Contraindications to the use of drugs: pregnancy, lactation, allergy to imipraminu or other ingredients that are subtotaling drug, tricyclic antidepressants other dybenzoazepinovoho subtotaling treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart beat (arrhythmia), severe kidney disease and / or liver; urinary retention (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children under 6 years. schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various Ointment (Meniere's disease); as an aid in the treatment of alcohol dependence. Non-selective monoamine Senior Medical Student subtotaling The main pharmaco-therapeutic effects: tymoleptychnu action, improves mood, reduces feelings of worth, is the central and peripheral m holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity; derivative product dybenzoazepinu; is to a group of drugs called tricyclic antidepressants; tymoleptychnu performs Stroke Volume action, improves mood, reduces sense of worth and has accompanying stimulatory activity, causes a reduction of motor zahalmovanosti, increases mental and Biopsy tone subtotaling the body, reveals the central and peripheral m-holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity. Pharmacotherapeutic group: N05AL01 - antipsychotic agents. Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients receiving than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in cases of prolonged use medication, seizures, neuroleptic malignant c-m reversible after discontinuation of the drug increase the level of prolactin serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, Resin Uptake and rigidity, weight here constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval subtotaling on electrocardiogram, tahiarytmiya "torsades de pointes"; liver - increase of liver enzymes, especially transaminases, AR.